252 related articles for article (PubMed ID: 19056733)
1. CD96 interaction with CD155 via its first Ig-like domain is modulated by alternative splicing or mutations in distal Ig-like domains.
Meyer D; Seth S; Albrecht J; Maier MK; du Pasquier L; Ravens I; Dreyer L; Burger R; Gramatzki M; Schwinzer R; Kremmer E; Foerster R; Bernhardt G
J Biol Chem; 2009 Jan; 284(4):2235-44. PubMed ID: 19056733
[TBL] [Abstract][Full Text] [Related]
2. The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1.
Seth S; Maier MK; Qiu Q; Ravens I; Kremmer E; Förster R; Bernhardt G
Biochem Biophys Res Commun; 2007 Dec; 364(4):959-65. PubMed ID: 17971293
[TBL] [Abstract][Full Text] [Related]
3. Interaction between nectin-1 and the human natural killer cell receptor CD96.
Holmes VM; Maluquer de Motes C; Richards PT; Roldan J; Bhargava AK; Orange JS; Krummenacher C
PLoS One; 2019; 14(2):e0212443. PubMed ID: 30759143
[TBL] [Abstract][Full Text] [Related]
4. Structural Basis for CD96 Immune Receptor Recognition of Nectin-like Protein-5, CD155.
Deuss FA; Watson GM; Fu Z; Rossjohn J; Berry R
Structure; 2019 Feb; 27(2):219-228.e3. PubMed ID: 30528596
[TBL] [Abstract][Full Text] [Related]
5. CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity.
Roman Aguilera A; Lutzky VP; Mittal D; Li XY; Stannard K; Takeda K; Bernhardt G; Teng MWL; Dougall WC; Smyth MJ
Oncoimmunology; 2018; 7(5):e1424677. PubMed ID: 29721390
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155).
Fuchs A; Cella M; Giurisato E; Shaw AS; Colonna M
J Immunol; 2004 Apr; 172(7):3994-8. PubMed ID: 15034010
[TBL] [Abstract][Full Text] [Related]
7. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
[TBL] [Abstract][Full Text] [Related]
8. Coming of Age: CD96 Emerges as Modulator of Immune Responses.
Georgiev H; Ravens I; Papadogianni G; Bernhardt G
Front Immunol; 2018; 9():1072. PubMed ID: 29868026
[TBL] [Abstract][Full Text] [Related]
9. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
Engel P; Wagner N; Miller AS; Tedder TF
J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells.
Seth S; Georgoudaki AM; Chambers BJ; Qiu Q; Kremmer E; Maier MK; Czeloth N; Ravens I; Foerster R; Bernhardt G
J Leukoc Biol; 2009 Jul; 86(1):91-101. PubMed ID: 19380711
[TBL] [Abstract][Full Text] [Related]
11. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.
Chan CJ; Martinet L; Gilfillan S; Souza-Fonseca-Guimaraes F; Chow MT; Town L; Ritchie DS; Colonna M; Andrews DM; Smyth MJ
Nat Immunol; 2014 May; 15(5):431-8. PubMed ID: 24658051
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
[TBL] [Abstract][Full Text] [Related]
13. A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions.
Xu Z; Jin B
Cell Mol Immunol; 2010 Jan; 7(1):11-9. PubMed ID: 20081873
[TBL] [Abstract][Full Text] [Related]
14. Enhanced ADCC activity of affinity maturated and Fc-engineered mini-antibodies directed against the AML stem cell antigen CD96.
Mohseni Nodehi S; Repp R; Kellner C; Bräutigam J; Staudinger M; Schub N; Peipp M; Gramatzki M; Humpe A
PLoS One; 2012; 7(8):e42426. PubMed ID: 22879978
[TBL] [Abstract][Full Text] [Related]
15. CD96 functions as a co-stimulatory receptor to enhance CD8
Chiang EY; de Almeida PE; de Almeida Nagata DE; Bowles KH; Du X; Chitre AS; Banta KL; Kwon Y; McKenzie B; Mittman S; Cubas R; Anderson KR; Warming S; Grogan JL
Eur J Immunol; 2020 Jun; 50(6):891-902. PubMed ID: 32043568
[TBL] [Abstract][Full Text] [Related]
16. Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.
Wang H; Qi J; Zhang S; Li Y; Tan S; Gao GF
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):988-996. PubMed ID: 30591568
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to alpha(v)beta3 integrin-containing membrane microdomains.
Mueller S; Wimmer E
J Biol Chem; 2003 Aug; 278(33):31251-60. PubMed ID: 12759359
[TBL] [Abstract][Full Text] [Related]
18. The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding.
Nemčovičová I; Zajonc DM
Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):851-62. PubMed ID: 24598754
[TBL] [Abstract][Full Text] [Related]
19. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
[TBL] [Abstract][Full Text] [Related]
20. CD155, an onco-immunologic molecule in human tumors.
Gao J; Zheng Q; Xin N; Wang W; Zhao C
Cancer Sci; 2017 Oct; 108(10):1934-1938. PubMed ID: 28730595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]